Search research articles
Contact Us
Filters
Showing results (161-170 of 188) with videos related to
Page
of 19
Sort By:
The British Journal of Dermatology
|
February 3, 2017
A phase I clinical trial demonstrates that nfP2X<sub>7</sub> -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S M Gilbert, A Gidley Baird, S Glazer, et al.
European Journal of Pharmacology
|
May 17, 1994
A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor
E K Potter, J A Barden, M J McCloskey, et al.
Analytical Biochemistry
|
July 23, 1999
Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry
J Proudfoot, A Barden, T A Mori, et al.
Journal of Neurocytology
|
May 16, 2001
P2X (purinergic) receptor redistribution in rabbit aorta following injury to endothelial cells and cholesterol feeding
T J Pulvirenti, J L Yin, X Chaufour, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 8, 2019
Effect of weight loss on neutrophil resolvins in the metabolic syndrome
A Barden, S Shinde, I-J Tsai, et al.
Electrophoresis
|
August 18, 1999
Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary
R A Worthington, L Brown, D Jellinek, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 16, 2003
Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy
J A Dunstan, T A Mori, A Barden, et al.
FEBS Letters
|
February 20, 2002
Point mutations confer loss of ATP-induced human P2X(7) receptor function
R A Worthington, M L Smart, B J Gu, et al.
Molecular and Cellular Endocrinology
|
June 1, 2002
Bioactivity of PTH/PTHrP analogs lacking the 1-14 N-terminal domain
Anne E Nelson, Julian A Barden, Erin A Martin, et al.
Molecular Vision
|
December 9, 2010
The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model
Heather L Chandler, Terah R Webb, Curtis A Barden, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 188) with videos related to
Sort By:
Page
of 19
The British Journal of Dermatology
|
February 3, 2017
A phase I clinical trial demonstrates that nfP2X<sub>7</sub> -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S M Gilbert, A Gidley Baird, S Glazer, et al.
European Journal of Pharmacology
|
May 17, 1994
A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor
E K Potter, J A Barden, M J McCloskey, et al.
Analytical Biochemistry
|
July 23, 1999
Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry
J Proudfoot, A Barden, T A Mori, et al.
Journal of Neurocytology
|
May 16, 2001
P2X (purinergic) receptor redistribution in rabbit aorta following injury to endothelial cells and cholesterol feeding
T J Pulvirenti, J L Yin, X Chaufour, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 8, 2019
Effect of weight loss on neutrophil resolvins in the metabolic syndrome
A Barden, S Shinde, I-J Tsai, et al.
Electrophoresis
|
August 18, 1999
Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary
R A Worthington, L Brown, D Jellinek, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 16, 2003
Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy
J A Dunstan, T A Mori, A Barden, et al.
FEBS Letters
|
February 20, 2002
Point mutations confer loss of ATP-induced human P2X(7) receptor function
R A Worthington, M L Smart, B J Gu, et al.
Molecular and Cellular Endocrinology
|
June 1, 2002
Bioactivity of PTH/PTHrP analogs lacking the 1-14 N-terminal domain
Anne E Nelson, Julian A Barden, Erin A Martin, et al.
Molecular Vision
|
December 9, 2010
The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model
Heather L Chandler, Terah R Webb, Curtis A Barden, et al.
Page
of 19